Taken together, these data suggest that EGF/HB-EGF-EGFR signalling is required for the proliferative ability of HPV+ cervical cancer cells, and this signalling axis is reduced in cells in which JNK is inhibited. This evidence concerns the gene HBEGF and cervical cancer.